| Line Item | 2025-03-31 | Y/Y |
|---|---|---|
| Revenue | $62.9M | -2.5% |
| Cost of Revenue | $30.6M | -11.7% |
| Gross Profit | $32.2M | +8.2% |
| R&D Expense | $7.1M | +7.4% |
| SG&A Expense | $30.0M | +16.3% |
| Operating Income | -$7.0M | -168.7% |
| Pre-tax Income | -$8.3M | -14.9% |
| Income Tax | $410K | -67.1% |
| Net Income | -$8.7M | -2.8% |
| EPS (Basic) | -$6.07 | -1796.9% |
| EPS (Diluted) | -$6.07 | -1796.9% |
| Line Item | 2025-03-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.9M | -39.9% |
| Accounts Receivable | $3.2M | -37.5% |
| Inventory | $7.0M | -10.0% |
| Current Assets | $21.2M | -21.8% |
| Total Assets | $26.8M | -25.1% |
| Current Liabilities | $42.9M | -4.7% |
| Long-term Debt | $2.4M | — |
| Line Item | 2025-03-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$4.1M | -179.8% |
| Capital Expenditures | $536K | +165.3% |
| Investing Cash Flow | -$536K | -165.3% |
| Financing Cash Flow | $3.4M | +168.6% |
| Free Cash Flow | -$4.7M | -193.8% |
| Total Liabilities |
| $63.9M |
| -6.4% |
| Stockholders' Equity | -$37.1M | -14.1% |